Code | System | Display |
01 | http://hl7.org/fhir/sid/cvx | DTP |
02 | http://hl7.org/fhir/sid/cvx | OPV |
03 | http://hl7.org/fhir/sid/cvx | MMR |
04 | http://hl7.org/fhir/sid/cvx | M/R |
05 | http://hl7.org/fhir/sid/cvx | measles |
06 | http://hl7.org/fhir/sid/cvx | rubella |
07 | http://hl7.org/fhir/sid/cvx | mumps |
08 | http://hl7.org/fhir/sid/cvx | Hep B, adolescent or pediatric |
09 | http://hl7.org/fhir/sid/cvx | Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed |
10 | http://hl7.org/fhir/sid/cvx | IPV |
11 | http://hl7.org/fhir/sid/cvx | pertussis |
12 | http://hl7.org/fhir/sid/cvx | diphtheria antitoxin |
13 | http://hl7.org/fhir/sid/cvx | TIG |
14 | http://hl7.org/fhir/sid/cvx | IG, unspecified formulation |
15 | http://hl7.org/fhir/sid/cvx | influenza, split (incl. purified surface antigen) |
16 | http://hl7.org/fhir/sid/cvx | influenza, whole |
17 | http://hl7.org/fhir/sid/cvx | Hib, unspecified formulation |
18 | http://hl7.org/fhir/sid/cvx | rabies, intramuscular injection |
19 | http://hl7.org/fhir/sid/cvx | BCG |
20 | http://hl7.org/fhir/sid/cvx | DTaP |
21 | http://hl7.org/fhir/sid/cvx | varicella |
22 | http://hl7.org/fhir/sid/cvx | DTP-Hib |
23 | http://hl7.org/fhir/sid/cvx | plague |
24 | http://hl7.org/fhir/sid/cvx | anthrax |
25 | http://hl7.org/fhir/sid/cvx | typhoid, oral |
26 | http://hl7.org/fhir/sid/cvx | cholera, unspecified formulation |
27 | http://hl7.org/fhir/sid/cvx | botulinum antitoxin |
28 | http://hl7.org/fhir/sid/cvx | DT (pediatric) |
29 | http://hl7.org/fhir/sid/cvx | CMVIG |
30 | http://hl7.org/fhir/sid/cvx | HBIG |
31 | http://hl7.org/fhir/sid/cvx | Hep A, pediatric, unspecified formulation |
32 | http://hl7.org/fhir/sid/cvx | meningococcal MPSV4 |
33 | http://hl7.org/fhir/sid/cvx | pneumococcal polysaccharide PPV23 |
34 | http://hl7.org/fhir/sid/cvx | RIG |
35 | http://hl7.org/fhir/sid/cvx | tetanus toxoid, adsorbed |
36 | http://hl7.org/fhir/sid/cvx | VZIG |
37 | http://hl7.org/fhir/sid/cvx | yellow fever |
38 | http://hl7.org/fhir/sid/cvx | rubella/mumps |
39 | http://hl7.org/fhir/sid/cvx | Japanese encephalitis SC |
40 | http://hl7.org/fhir/sid/cvx | rabies, intradermal injection |
41 | http://hl7.org/fhir/sid/cvx | typhoid, parenteral |
42 | http://hl7.org/fhir/sid/cvx | Hep B, adolescent/high risk infant |
43 | http://hl7.org/fhir/sid/cvx | Hep B, adult |
44 | http://hl7.org/fhir/sid/cvx | Hep B, dialysis |
45 | http://hl7.org/fhir/sid/cvx | Hep B, unspecified formulation |
46 | http://hl7.org/fhir/sid/cvx | Hib (PRP-D) |
47 | http://hl7.org/fhir/sid/cvx | Hib (HbOC) |
48 | http://hl7.org/fhir/sid/cvx | Hib (PRP-T) |
49 | http://hl7.org/fhir/sid/cvx | Hib (PRP-OMP) |
50 | http://hl7.org/fhir/sid/cvx | DTaP-Hib |
51 | http://hl7.org/fhir/sid/cvx | Hib-Hep B |
52 | http://hl7.org/fhir/sid/cvx | Hep A, adult |
53 | http://hl7.org/fhir/sid/cvx | typhoid, parenteral, AKD (U.S. military) |
54 | http://hl7.org/fhir/sid/cvx | adenovirus, type 4 |
55 | http://hl7.org/fhir/sid/cvx | adenovirus, type 7 |
56 | http://hl7.org/fhir/sid/cvx | dengue fever tetravalent |
57 | http://hl7.org/fhir/sid/cvx | hantavirus |
58 | http://hl7.org/fhir/sid/cvx | Hep C |
59 | http://hl7.org/fhir/sid/cvx | Hep E |
60 | http://hl7.org/fhir/sid/cvx | herpes simplex 2 |
61 | http://hl7.org/fhir/sid/cvx | HIV |
62 | http://hl7.org/fhir/sid/cvx | HPV, quadrivalent |
63 | http://hl7.org/fhir/sid/cvx | Junin virus |
64 | http://hl7.org/fhir/sid/cvx | leishmaniasis |
65 | http://hl7.org/fhir/sid/cvx | leprosy |
66 | http://hl7.org/fhir/sid/cvx | Lyme disease |
67 | http://hl7.org/fhir/sid/cvx | malaria |
68 | http://hl7.org/fhir/sid/cvx | melanoma |
69 | http://hl7.org/fhir/sid/cvx | parainfluenza-3 |
70 | http://hl7.org/fhir/sid/cvx | Q fever |
71 | http://hl7.org/fhir/sid/cvx | RSV-IGIV |
72 | http://hl7.org/fhir/sid/cvx | rheumatic fever |
73 | http://hl7.org/fhir/sid/cvx | Rift Valley fever |
74 | http://hl7.org/fhir/sid/cvx | rotavirus, tetravalent |
75 | http://hl7.org/fhir/sid/cvx | vaccinia (smallpox) |
76 | http://hl7.org/fhir/sid/cvx | Staphylococcus bacterio lysate |
77 | http://hl7.org/fhir/sid/cvx | Tick-borne encephalitis vaccine (non-US) |
78 | http://hl7.org/fhir/sid/cvx | tularemia vaccine |
79 | http://hl7.org/fhir/sid/cvx | vaccinia immune globulin |
80 | http://hl7.org/fhir/sid/cvx | VEE, live |
81 | http://hl7.org/fhir/sid/cvx | VEE, inactivated |
82 | http://hl7.org/fhir/sid/cvx | adenovirus, unspecified formulation |
83 | http://hl7.org/fhir/sid/cvx | Hep A, ped/adol, 2 dose |
84 | http://hl7.org/fhir/sid/cvx | Hep A, ped/adol, 3 dose |
85 | http://hl7.org/fhir/sid/cvx | Hep A, unspecified formulation |
86 | http://hl7.org/fhir/sid/cvx | IG |
87 | http://hl7.org/fhir/sid/cvx | IGIV |
88 | http://hl7.org/fhir/sid/cvx | influenza, unspecified formulation |
89 | http://hl7.org/fhir/sid/cvx | polio, unspecified formulation |
90 | http://hl7.org/fhir/sid/cvx | rabies, unspecified formulation |
91 | http://hl7.org/fhir/sid/cvx | typhoid, unspecified formulation |
92 | http://hl7.org/fhir/sid/cvx | VEE, unspecified formulation |
93 | http://hl7.org/fhir/sid/cvx | RSV-MAb |
94 | http://hl7.org/fhir/sid/cvx | MMRV |
95 | http://hl7.org/fhir/sid/cvx | TST-OT tine test |
96 | http://hl7.org/fhir/sid/cvx | TST-PPD intradermal |
97 | http://hl7.org/fhir/sid/cvx | TST-PPD tine test |
98 | http://hl7.org/fhir/sid/cvx | TST, unspecified formulation |
99 | http://hl7.org/fhir/sid/cvx | RESERVED - do not use |
100 | http://hl7.org/fhir/sid/cvx | pneumococcal conjugate PCV 7 |
101 | http://hl7.org/fhir/sid/cvx | typhoid, ViCPs |
102 | http://hl7.org/fhir/sid/cvx | DTP-Hib-Hep B |
103 | http://hl7.org/fhir/sid/cvx | meningococcal C conjugate |
104 | http://hl7.org/fhir/sid/cvx | Hep A-Hep B |
105 | http://hl7.org/fhir/sid/cvx | vaccinia (smallpox) diluted |
106 | http://hl7.org/fhir/sid/cvx | DTaP, 5 pertussis antigens |
107 | http://hl7.org/fhir/sid/cvx | DTaP, unspecified formulation |
108 | http://hl7.org/fhir/sid/cvx | meningococcal ACWY, unspecified formulation |
109 | http://hl7.org/fhir/sid/cvx | pneumococcal, unspecified formulation |
110 | http://hl7.org/fhir/sid/cvx | DTaP-Hep B-IPV |
111 | http://hl7.org/fhir/sid/cvx | influenza, live, intranasal |
112 | http://hl7.org/fhir/sid/cvx | tetanus toxoid, unspecified formulation |
113 | http://hl7.org/fhir/sid/cvx | Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed |
114 | http://hl7.org/fhir/sid/cvx | meningococcal MCV4P |
115 | http://hl7.org/fhir/sid/cvx | Tdap |
116 | http://hl7.org/fhir/sid/cvx | rotavirus, pentavalent |
117 | http://hl7.org/fhir/sid/cvx | VZIG (IND) |
118 | http://hl7.org/fhir/sid/cvx | HPV, bivalent |
119 | http://hl7.org/fhir/sid/cvx | rotavirus, monovalent |
120 | http://hl7.org/fhir/sid/cvx | DTaP-Hib-IPV |
121 | http://hl7.org/fhir/sid/cvx | zoster live |
122 | http://hl7.org/fhir/sid/cvx | rotavirus, unspecified formulation |
123 | http://hl7.org/fhir/sid/cvx | influenza, H5N1-1203 |
125 | http://hl7.org/fhir/sid/cvx | Novel Influenza-H1N1-09, nasal |
126 | http://hl7.org/fhir/sid/cvx | Novel influenza-H1N1-09, preservative-free |
127 | http://hl7.org/fhir/sid/cvx | Novel influenza-H1N1-09 |
128 | http://hl7.org/fhir/sid/cvx | Novel Influenza-H1N1-09, all formulations |
129 | http://hl7.org/fhir/sid/cvx | Japanese Encephalitis, unspecified formulation |
130 | http://hl7.org/fhir/sid/cvx | DTaP-IPV |
131 | http://hl7.org/fhir/sid/cvx | typhus, historical |
132 | http://hl7.org/fhir/sid/cvx | DTaP-IPV-HIB-HEP B, historical |
133 | http://hl7.org/fhir/sid/cvx | Pneumococcal conjugate PCV 13 |
134 | http://hl7.org/fhir/sid/cvx | Japanese Encephalitis IM |
135 | http://hl7.org/fhir/sid/cvx | Influenza, high dose seasonal |
136 | http://hl7.org/fhir/sid/cvx | Meningococcal MCV4O |
137 | http://hl7.org/fhir/sid/cvx | HPV, unspecified formulation |
138 | http://hl7.org/fhir/sid/cvx | Td (adult) |
139 | http://hl7.org/fhir/sid/cvx | Td(adult) unspecified formulation |
140 | http://hl7.org/fhir/sid/cvx | Influenza, seasonal, injectable, preservative free |
141 | http://hl7.org/fhir/sid/cvx | Influenza, seasonal, injectable |
142 | http://hl7.org/fhir/sid/cvx | tetanus toxoid, not adsorbed |
143 | http://hl7.org/fhir/sid/cvx | Adenovirus types 4 and 7 |
144 | http://hl7.org/fhir/sid/cvx | influenza, seasonal, intradermal, preservative free |
145 | http://hl7.org/fhir/sid/cvx | RSV-MAb (new) |
146 | http://hl7.org/fhir/sid/cvx | DTaP,IPV,Hib,HepB |
147 | http://hl7.org/fhir/sid/cvx | meningococcal MCV4, unspecified formulation |
148 | http://hl7.org/fhir/sid/cvx | Meningococcal C/Y-HIB PRP |
149 | http://hl7.org/fhir/sid/cvx | influenza, live, intranasal, quadrivalent |
150 | http://hl7.org/fhir/sid/cvx | influenza, injectable, quadrivalent, preservative free |
151 | http://hl7.org/fhir/sid/cvx | influenza nasal, unspecified formulation |
152 | http://hl7.org/fhir/sid/cvx | Pneumococcal Conjugate, unspecified formulation |
153 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, MDCK, preservative free |
154 | http://hl7.org/fhir/sid/cvx | Hep A, IG |
155 | http://hl7.org/fhir/sid/cvx | influenza, recombinant, injectable, preservative free |
156 | http://hl7.org/fhir/sid/cvx | Rho(D)-IG |
157 | http://hl7.org/fhir/sid/cvx | Rho(D) -IG IM |
158 | http://hl7.org/fhir/sid/cvx | influenza, injectable, quadrivalent |
159 | http://hl7.org/fhir/sid/cvx | Rho(D) - Unspecified formulation |
160 | http://hl7.org/fhir/sid/cvx | Influenza A monovalent (H5N1), ADJUVANTED-2013 |
161 | http://hl7.org/fhir/sid/cvx | Influenza, injectable,quadrivalent, preservative free, pediatric |
162 | http://hl7.org/fhir/sid/cvx | meningococcal B, recombinant |
163 | http://hl7.org/fhir/sid/cvx | meningococcal B, OMV |
164 | http://hl7.org/fhir/sid/cvx | meningococcal B, unspecified |
165 | http://hl7.org/fhir/sid/cvx | HPV9 |
166 | http://hl7.org/fhir/sid/cvx | influenza, intradermal, quadrivalent, preservative free |
167 | http://hl7.org/fhir/sid/cvx | meningococcal, unknown serogroups |
168 | http://hl7.org/fhir/sid/cvx | influenza, trivalent, adjuvanted |
169 | http://hl7.org/fhir/sid/cvx | Hep A, live attenuated |
170 | http://hl7.org/fhir/sid/cvx | DTAP/IPV/HIB - non-US |
171 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, MDCK, preservative free, quadrivalent |
172 | http://hl7.org/fhir/sid/cvx | cholera, WC-rBS |
173 | http://hl7.org/fhir/sid/cvx | cholera, BivWC |
174 | http://hl7.org/fhir/sid/cvx | cholera, live attenuated |
175 | http://hl7.org/fhir/sid/cvx | Rabies - IM Diploid cell culture |
176 | http://hl7.org/fhir/sid/cvx | Rabies - IM fibroblast culture |
177 | http://hl7.org/fhir/sid/cvx | PCV10 |
178 | http://hl7.org/fhir/sid/cvx | OPV bivalent |
179 | http://hl7.org/fhir/sid/cvx | OPV ,monovalent, unspecified |
180 | http://hl7.org/fhir/sid/cvx | tetanus immune globulin |
181 | http://hl7.org/fhir/sid/cvx | anthrax immune globulin |
182 | http://hl7.org/fhir/sid/cvx | OPV, Unspecified |
183 | http://hl7.org/fhir/sid/cvx | Yellow fever vaccine - alt |
184 | http://hl7.org/fhir/sid/cvx | Yellow fever, unspecified formulation |
185 | http://hl7.org/fhir/sid/cvx | influenza, recombinant, quadrivalent,injectable, preservative free |
186 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, MDCK, quadrivalent, preservative |
187 | http://hl7.org/fhir/sid/cvx | zoster recombinant |
188 | http://hl7.org/fhir/sid/cvx | zoster, unspecified formulation |
189 | http://hl7.org/fhir/sid/cvx | HepB-CpG |
190 | http://hl7.org/fhir/sid/cvx | Typhoid conjugate vaccine (TCV) |
191 | http://hl7.org/fhir/sid/cvx | meningococcal A polysaccharide (non-US) |
192 | http://hl7.org/fhir/sid/cvx | meningococcal AC polysaccharide (non-US) |
193 | http://hl7.org/fhir/sid/cvx | Hep A-Hep B, pediatric/adolescent |
194 | http://hl7.org/fhir/sid/cvx | Influenza, Southern Hemisphere |
195 | http://hl7.org/fhir/sid/cvx | DT, IPV adsorbed |
196 | http://hl7.org/fhir/sid/cvx | Td, adsorbed, preservative free, adult use, Lf unspecified |
197 | http://hl7.org/fhir/sid/cvx | influenza, high-dose, quadrivalent |
198 | http://hl7.org/fhir/sid/cvx | DTP-hepB-Hib Pentavalent Non-US |
200 | http://hl7.org/fhir/sid/cvx | influenza, Southern Hemisphere, pediatric, preservative free |
201 | http://hl7.org/fhir/sid/cvx | influenza, Southern Hemisphere, preservative free |
202 | http://hl7.org/fhir/sid/cvx | influenza, Southern Hemisphere, quadrivalent, with preservative |
203 | http://hl7.org/fhir/sid/cvx | meningococcal conjugate quadrivalent, MenACWY-TT (MCV4) |
204 | http://hl7.org/fhir/sid/cvx | Ebola Zaire vaccine, live, recombinant, 1mL dose |
205 | http://hl7.org/fhir/sid/cvx | Influenza vaccine, quadrivalent, adjuvanted |
206 | http://hl7.org/fhir/sid/cvx | Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection |
207 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose |
208 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose |
210 | http://hl7.org/fhir/sid/cvx | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL |
211 | http://hl7.org/fhir/sid/cvx | COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL |
212 | http://hl7.org/fhir/sid/cvx | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL |
213 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED |
214 | http://hl7.org/fhir/sid/cvx | Ebola, unspecified |
215 | http://hl7.org/fhir/sid/cvx | Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF |
216 | http://hl7.org/fhir/sid/cvx | Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF |
217 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose |
218 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose |
219 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose |
220 | http://hl7.org/fhir/sid/cvx | HepB recombinant, 3-antigen, Al(OH)3 |
221 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose |
222 | http://hl7.org/fhir/sid/cvx | Tick-borne encephalitis, unspecified |
223 | http://hl7.org/fhir/sid/cvx | Tick-borne encephalitis, inactivated, PF, 0.25mL |
224 | http://hl7.org/fhir/sid/cvx | Tick-borne encephalitis, inactivated, PF, 0.5mL |
225 | http://hl7.org/fhir/sid/cvx | COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL |
226 | http://hl7.org/fhir/sid/cvx | COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL |
227 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose |
228 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose |
229 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose |
230 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL |
231 | http://hl7.org/fhir/sid/cvx | influenza, Southern Hemisphere, high-dose, quadrivalent |
300 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose |
301 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose |
302 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose |
303 | http://hl7.org/fhir/sid/cvx | RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF |
304 | http://hl7.org/fhir/sid/cvx | Respiratory syncytial virus (RSV), unspecified |
305 | http://hl7.org/fhir/sid/cvx | RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF |
306 | http://hl7.org/fhir/sid/cvx | RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months |
307 | http://hl7.org/fhir/sid/cvx | RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months |
308 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL |
309 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL |
310 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL |
311 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL |
312 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL |
313 | http://hl7.org/fhir/sid/cvx | COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL |
314 | http://hl7.org/fhir/sid/cvx | Respiratory syncytial virus (RSV) vaccine, unspecified |
315 | http://hl7.org/fhir/sid/cvx | Respiratory syncytial virus (RSV) MAB, unspecified |
316 | http://hl7.org/fhir/sid/cvx | meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF |
317 | http://hl7.org/fhir/sid/cvx | Chikungunya live attenuated vaccine, 0.5 mL, PF |
500 | http://hl7.org/fhir/sid/cvx | COVID-19 Non-US Vaccine, Product Unknown |
501 | http://hl7.org/fhir/sid/cvx | COVID-19 IV Non-US Vaccine (QAZCOVID-IN) |
502 | http://hl7.org/fhir/sid/cvx | COVID-19 IV Non-US Vaccine (COVAXIN) |
503 | http://hl7.org/fhir/sid/cvx | COVID-19 LAV Non-US Vaccine (COVIVAC) |
504 | http://hl7.org/fhir/sid/cvx | COVID-19 VVnr Non-US Vaccine (Sputnik Light) |
505 | http://hl7.org/fhir/sid/cvx | COVID-19 VVnr Non-US Vaccine (Sputnik V) |
506 | http://hl7.org/fhir/sid/cvx | COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology |
507 | http://hl7.org/fhir/sid/cvx | COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) |
508 | http://hl7.org/fhir/sid/cvx | COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) |
509 | http://hl7.org/fhir/sid/cvx | COVID-19 PS Non-US Vaccine (EpiVacCorona) |
510 | http://hl7.org/fhir/sid/cvx | COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) |
511 | http://hl7.org/fhir/sid/cvx | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) |
512 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) |
513 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) |
514 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) |
515 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) |
516 | http://hl7.org/fhir/sid/cvx | COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) |
517 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) |
518 | http://hl7.org/fhir/sid/cvx | COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) |
519 | http://hl7.org/fhir/sid/cvx | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna |
520 | http://hl7.org/fhir/sid/cvx | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech |
521 | http://hl7.org/fhir/sid/cvx | COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK |
801 | http://hl7.org/fhir/sid/cvx | AS03 Adjuvant |
998 | http://hl7.org/fhir/sid/cvx | no vaccine administered |
999 | http://hl7.org/fhir/sid/cvx | unknown |
J07 | http://www.whocc.no/atc | VACCINES |
J07A | http://www.whocc.no/atc | BACTERIAL VACCINES |
J07AC | http://www.whocc.no/atc | Anthrax vaccines |
J07AC01 | http://www.whocc.no/atc | anthrax antigen |
J07AD | http://www.whocc.no/atc | Brucellosis vaccines |
J07AD01 | http://www.whocc.no/atc | brucella antigen |
J07AE | http://www.whocc.no/atc | Cholera vaccines |
J07AE01 | http://www.whocc.no/atc | cholera, inactivated, whole cell |
J07AE02 | http://www.whocc.no/atc | cholera, live attenuated |
J07AE51 | http://www.whocc.no/atc | cholera, combinations with typhoid vaccine, inactivated, whole cell |
J07AF | http://www.whocc.no/atc | Diphtheria vaccines |
J07AF01 | http://www.whocc.no/atc | diphtheria toxoid |
J07AG | http://www.whocc.no/atc | Haemophilus influenzae B vaccines |
J07AG01 | http://www.whocc.no/atc | haemophilus influenzae B, purified antigen conjugated |
J07AG51 | http://www.whocc.no/atc | haemophilus influenzae B, combinations with toxoids |
J07AG52 | http://www.whocc.no/atc | haemophilus influenzae B, combinations with pertussis and toxoids |
J07AG53 | http://www.whocc.no/atc | haemophilus influenzae B, combinations with meningococcus C, conjugated |
J07AH | http://www.whocc.no/atc | Meningococcal vaccines |
J07AH01 | http://www.whocc.no/atc | meningococcus A, purified polysaccharides antigen |
J07AH02 | http://www.whocc.no/atc | other meningococcal monovalent purified polysaccharides antigen |
J07AH03 | http://www.whocc.no/atc | meningococcus A,C, bivalent purified polysaccharides antigen |
J07AH04 | http://www.whocc.no/atc | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen |
J07AH05 | http://www.whocc.no/atc | other meningococcal polyvalent purified polysaccharides antigen |
J07AH06 | http://www.whocc.no/atc | meningococcus B, outer membrane vesicle vaccine |
J07AH07 | http://www.whocc.no/atc | meningococcus C, purified polysaccharides antigen conjugated |
J07AH08 | http://www.whocc.no/atc | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated |
J07AH09 | http://www.whocc.no/atc | meningococcus B, multicomponent vaccine |
J07AH10 | http://www.whocc.no/atc | meningococcus A, purified polysaccharides antigen conjugated |
J07AJ | http://www.whocc.no/atc | Pertussis vaccines |
J07AJ01 | http://www.whocc.no/atc | pertussis, inactivated, whole cell |
J07AJ02 | http://www.whocc.no/atc | pertussis, purified antigen |
J07AJ51 | http://www.whocc.no/atc | pertussis, inactivated, whole cell, combinations with toxoids |
J07AJ52 | http://www.whocc.no/atc | pertussis, purified antigen, combinations with toxoids |
J07AK | http://www.whocc.no/atc | Plague vaccines |
J07AK01 | http://www.whocc.no/atc | plague, inactivated, whole cell |
J07AL | http://www.whocc.no/atc | Pneumococcal vaccines |
J07AL01 | http://www.whocc.no/atc | pneumococcus, purified polysaccharides antigen |
J07AL02 | http://www.whocc.no/atc | pneumococcus, purified polysaccharides antigen conjugated |
J07AL52 | http://www.whocc.no/atc | pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated |
J07AM | http://www.whocc.no/atc | Tetanus vaccines |
J07AM01 | http://www.whocc.no/atc | tetanus toxoid |
J07AM51 | http://www.whocc.no/atc | tetanus toxoid, combinations with diphtheria toxoid |
J07AM52 | http://www.whocc.no/atc | tetanus toxoid, combinations with tetanus immunoglobulin |
J07AN | http://www.whocc.no/atc | Tuberculosis vaccines |
J07AN01 | http://www.whocc.no/atc | tuberculosis, live attenuated |
J07AP | http://www.whocc.no/atc | Typhoid vaccines |
J07AP01 | http://www.whocc.no/atc | typhoid, oral, live attenuated |
J07AP02 | http://www.whocc.no/atc | typhoid, inactivated, whole cell |
J07AP03 | http://www.whocc.no/atc | typhoid, purified polysaccharide antigen |
J07AP10 | http://www.whocc.no/atc | typhoid, combinations with paratyphi types |
J07AR | http://www.whocc.no/atc | Typhus (exanthematicus) vaccines |
J07AR01 | http://www.whocc.no/atc | typhus exanthematicus, inactivated, whole cell |
J07AX | http://www.whocc.no/atc | Other bacterial vaccines |
J07B | http://www.whocc.no/atc | VIRAL VACCINES |
J07BA | http://www.whocc.no/atc | Encephalitis vaccines |
J07BA01 | http://www.whocc.no/atc | encephalitis, tick borne, inactivated, whole virus |
J07BA02 | http://www.whocc.no/atc | encephalitis, Japanese, inactivated, whole virus |
J07BA03 | http://www.whocc.no/atc | encephalitis, Japanese, live attenuated |
J07BB | http://www.whocc.no/atc | Influenza vaccines |
J07BB01 | http://www.whocc.no/atc | influenza, inactivated, whole virus |
J07BB02 | http://www.whocc.no/atc | influenza, inactivated, split virus or surface antigen |
J07BB03 | http://www.whocc.no/atc | influenza, live attenuated |
J07BB04 | http://www.whocc.no/atc | influenza, virus like particles |
J07BC | http://www.whocc.no/atc | Hepatitis vaccines |
J07BC01 | http://www.whocc.no/atc | hepatitis B, purified antigen |
J07BC02 | http://www.whocc.no/atc | hepatitis A, inactivated, whole virus |
J07BC20 | http://www.whocc.no/atc | combinations |
J07BD | http://www.whocc.no/atc | Measles vaccines |
J07BD01 | http://www.whocc.no/atc | measles, live attenuated |
J07BD51 | http://www.whocc.no/atc | measles, combinations with mumps, live attenuated |
J07BD52 | http://www.whocc.no/atc | measles, combinations with mumps and rubella, live attenuated |
J07BD53 | http://www.whocc.no/atc | measles, combinations with rubella, live attenuated |
J07BD54 | http://www.whocc.no/atc | measles, combinations with mumps, rubella and varicella, live attenuated |
J07BE | http://www.whocc.no/atc | Mumps vaccines |
J07BE01 | http://www.whocc.no/atc | mumps, live attenuated |
J07BF | http://www.whocc.no/atc | Poliomyelitis vaccines |
J07BF01 | http://www.whocc.no/atc | poliomyelitis oral, monovalent, live attenuated |
J07BF02 | http://www.whocc.no/atc | poliomyelitis oral, trivalent, live attenuated |
J07BF03 | http://www.whocc.no/atc | poliomyelitis, trivalent, inactivated, whole virus |
J07BF04 | http://www.whocc.no/atc | poliomyelitis oral, bivalent, live attenuated |
J07BG | http://www.whocc.no/atc | Rabies vaccines |
J07BG01 | http://www.whocc.no/atc | rabies, inactivated, whole virus |
J07BH | http://www.whocc.no/atc | Rota virus diarrhea vaccines |
J07BH01 | http://www.whocc.no/atc | rota virus, live attenuated |
J07BH02 | http://www.whocc.no/atc | rota virus, pentavalent, live, reassorted |
J07BJ | http://www.whocc.no/atc | Rubella vaccines |
J07BJ01 | http://www.whocc.no/atc | rubella, live attenuated |
J07BJ51 | http://www.whocc.no/atc | rubella, combinations with mumps, live attenuated |
J07BK | http://www.whocc.no/atc | Varicella zoster vaccines |
J07BK01 | http://www.whocc.no/atc | varicella, live attenuated |
J07BK02 | http://www.whocc.no/atc | zoster, live attenuated |
J07BK03 | http://www.whocc.no/atc | zoster, purified antigen |
J07BL | http://www.whocc.no/atc | Yellow fever vaccines |
J07BL01 | http://www.whocc.no/atc | yellow fever, live attenuated |
J07BM | http://www.whocc.no/atc | Papillomavirus vaccines |
J07BM01 | http://www.whocc.no/atc | papillomavirus (human types 6, 11, 16, 18) |
J07BM02 | http://www.whocc.no/atc | papillomavirus (human types 16, 18) |
J07BM03 | http://www.whocc.no/atc | papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) |
J07BX | http://www.whocc.no/atc | Other viral vaccines |
J07BX01 | http://www.whocc.no/atc | smallpox vaccines |
J07BX02 | http://www.whocc.no/atc | ebola vaccines |
J07C | http://www.whocc.no/atc | BACTERIAL AND VIRAL VACCINES, COMBINED |
J07CA | http://www.whocc.no/atc | Bacterial and viral vaccines, combined |
J07CA01 | http://www.whocc.no/atc | diphtheria-poliomyelitis-tetanus |
J07CA02 | http://www.whocc.no/atc | diphtheria-pertussis-poliomyelitis-tetanus |
J07CA03 | http://www.whocc.no/atc | diphtheria-rubella-tetanus |
J07CA04 | http://www.whocc.no/atc | haemophilus influenzae B and poliomyelitis |
J07CA05 | http://www.whocc.no/atc | diphtheria-hepatitis B-pertussis-tetanus |
J07CA06 | http://www.whocc.no/atc | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus |
J07CA07 | http://www.whocc.no/atc | diphtheria-hepatitis B-tetanus |
J07CA08 | http://www.whocc.no/atc | haemophilus influenzae B and hepatitis B |
J07CA09 | http://www.whocc.no/atc | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B |
J07CA10 | http://www.whocc.no/atc | typhoid-hepatitis A |
J07CA11 | http://www.whocc.no/atc | diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B |
J07CA12 | http://www.whocc.no/atc | diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B |
J07CA13 | http://www.whocc.no/atc | diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C |
J07X | http://www.whocc.no/atc | OTHER VACCINES |